Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT05967546
Starting soon Observational

Deep Learning for Intelligent Identification of Arrhythmias

NCT05967546 · tracked via the Priya Life Science China tracker
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Started
2024-12-30
Last updated
2024-04-04

Condition(s) studied

Arrhythmia

Investigational drug(s) / intervention(s)

Observational

Observational: No interventions will be given to patients.

Study summary

This study aims to design and train a deep learning model for the diagnosis of different arrhythmias.

Eligibility

Sex
ALL
Min age
3 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * For retrospective study: 1.Patients with arrhythmia diagnosed by routine surface 12-lead electrocardiogram or Holter; 2.The type of arrhythmia is diagnosed by intracardiac electrophysiological examination. * For prospective study: 1.Patients with arrhythmia diagnosed by routine surface 12-lead electrocardiogram or Holter; 2.Intracardiac electrophysiological examination is planned. Exclusion Criteria: * Lack of routine surface 12-lead electrocardiogram or holter data; * Lack of intracardiac electrophysiological examination; * Patients refused to sign informed consent and refused to participate in the study.

Primary outcome measure(s)

  • A deep learning model designed to intelligently identify the types of arrhythmia. — 1 day after the enrollment.
    The model is trained on the training set, the best model and hyperparameters are selected through the verification set, and finally the model results are tested on the test set.

Trial sites (1)

FacilityCityRegionStatus
First Affiliated Hospital of Xi'an Jiantong University Xi'an Shaanxi

More First Affiliated Hospital Xi'an Jiaotong University trials in China

Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN) Starting soon
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients Recruiting
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation Starting soon
Peripheral Blood Lipidomic and Ceramide Profiles in Atrial Fibrillation Recruiting
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias Starting soon

Other trials for the same condition

Arrhythmia Cohort Study Starting soon
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting Recruiting
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation Starting soon
Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement Active, not recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05967546 on ClinicalTrials.gov ↗ ← All trials in China